Cost Effectiveness of Blinatumomab Versus Inotuzumab...

  • Main
  • 2019 / 6
  • Cost Effectiveness of Blinatumomab Versus Inotuzumab...

Cost Effectiveness of Blinatumomab Versus Inotuzumab Ozogamicin in Adult Patients with Relapsed or Refractory B-Cell Precursor Acute Lymphoblastic Leukemia in the United States

Delea, Thomas E., Zhang, Xinke, Amdahl, Jordan, Boyko, Diana, Dirnberger, Franziska, Campioni, Marco, Cong, Ze
How much do you like this book?
What’s the quality of the file?
Download the book for quality assessment
What’s the quality of the downloaded files?
Language:
english
Journal:
PharmacoEconomics
DOI:
10.1007/s40273-019-00812-6
Date:
June, 2019
File:
PDF, 1.20 MB
english, 2019
Conversion to is in progress
Conversion to is failed